Standex International (SXI) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Jul, 2026Executive summary
Achieved highest sales quarter since 2020 divestiture, with Q2 FY25 net sales up 6.4% year-over-year to $189.8M, driven by acquisitions despite organic declines.
Record adjusted operating margin of 18.7% (+150 bps YoY), with adjusted gross margin at 40.9%.
Amran/Narayan Group acquisition, the largest in company history, exceeded expectations and contributed to strong sales and integration milestones.
Exposure to fast-growth end markets (electrical grid, space, defense, EV, renewables) now exceeds 20% of total sales.
New product sales more than doubled year-on-year, totaling $14.5M in Q2; over a dozen launches planned for FY25.
Financial highlights
Net sales: $189.8M (+6.4% YoY); organic growth -8.2%, acquisitions +15.3%, FX -0.7%.
Adjusted operating income: $35.5M (+15.4% YoY); adjusted operating margin: 18.7% (+150 bps YoY).
Adjusted net income: $22.9M (+1.0% YoY); adjusted EPS: $1.91 (flat YoY); GAAP net income: $0.9M–$1.3M (down sharply YoY).
Free cash flow: $2.1M–$2.2M, down from $19.5M YoY, impacted by ~$11M in one-time acquisition expenses.
Q2 gross margin: 37.6% (down 260 bps YoY); adjusted gross margin: 40.9% (+60 bps YoY).
Outlook and guidance
Q3 FY25 expected to see moderately to significantly higher revenue and slightly to moderately higher adjusted operating margin, led by Amran/Narayan and electronics demand.
FY25 sales into fast-growth markets projected at ~$170M; >$340M by FY28, over 30% of total sales.
FY28 long-term targets raised to >$1.15B sales, >23% adjusted operating margin, >15.5% ROIC.
Capital expenditures for FY25 expected between $30M–$35M; Q3 FY25 interest expense projected at $7M–$7.5M.
Over a dozen new product launches planned for FY25, expected to add ~200 bps of incremental growth.
Latest events from Standex International
- Q3 FY26 sales rose 8.1% with margin expansion and robust growth in electronics and defense.SXI
Investor presentation15 Jul 2026 - Q2 FY26 delivered double-digit sales growth, margin expansion, and record order intake.SXI
Q2 20269 Jul 2026 - Organic growth, margin expansion, and innovation drive strong performance and future outlook.SXI
Investor presentation29 Jun 2026 - Margin and organic growth driven by innovation, fast growth markets, and portfolio optimization.SXI
46th Annual William Blair Growth Stock Conference10 Jun 2026 - Q3 FY26 delivered strong sales, margin gains, and portfolio focus, with robust growth outlook.SXI
Q3 20266 May 2026 - Record profit, margin gains, and new launches set up >20% fast market growth for FY25.SXI
Q4 20242 Feb 2026 - Record margin and a $462M acquisition set the stage for sequential growth.SXI
Q1 202518 Jan 2026 - Record margins and 17.2% sales growth driven by acquisitions and fast growth markets.SXI
Q3 202523 Dec 2025 - Proxy covers director elections, pay, governance, risk, and ESG, with all proposals recommended.SXI
Proxy Filing1 Dec 2025